US, India to Work Together on COVID-19 Vaccine, Pompeo Indicates ‘Talks Beyond Virus Battle’

New Delhi: In the battle against coronavirus, the US declared that it will cooperate with India on Covid-19 treatments and antibodies so as to guarantee the two nations approach materials like PPEs and Hydroxychloroquine (HCQ), expressed a report in The Times of India.

In a video chat with writers, US Secretary of State Mike Pompeo told TOI: “We (US and India) keep on discussing the greater issues, free and open Indo-Pacific, challenge of China and exchange.”

He further said that Washington was likewise focusing on supply chains. “We need to work the stock chains that the two nations approach in regions that are significant for our national security,” Pompeo included.

India, the biggest maker of HCQ, had as of late consented to lift a prohibition on the fare of the counter malarial medication, HCQ, following a phone discussion between US President Donald Trump and Prime Minister Narendra Modi.

A report in DNA expressed that US has given India a measure of about $5.9 million in wellbeing help as help to control the spread of the lethal infection in the nation.

The affirmed coronavirus loss of life in the United States arrived at 32,917 on Thursday, as indicated by a count by Johns Hopkins University.

The cost as of 8:30 pm (0030 GMT Friday) denoted an expansion of 4,491 passings in the previous 24 hours, by a long shot the most noteworthy every day cost in the pandemic up until this point. Be that as it may, the figure likely incorporates “plausible” passings identified with Covid-19, which were not recently included.